Reconciled ClinicalTrials.gov v2 Protocol Specification
| Protocol Field | Verified Registry Value |
|---|---|
| NCT Identifier | NCT06397313 |
| Consolidated Lead Sponsor | Ryvu Therapeutics SA |
| Therapeutic Condition Cohort | Oncology and Hematology |
| Clinical Trial Phase | Phase II |
| Overall Recruitment Status | TERMINATED |
| Registered Enrollment | 36 participants (ACTUAL) |
| Registered Start Date | 2024-09-19 |
| WhyStopped Classification | Strategic / Business / Sponsor Decision |
Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.